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Abstract
Background: The mouse is an important and widely utilized animal model for bone marrow
transplant (BMT) translational studies. Here, we document the course of an unexpected increase
in mortality of congenic mice that underwent BMT.
Methods: Thirty five BMTs were analyzed for survival differences utilizing the Log Rank test.
Affected animals were evaluated by physical examination, necropsy, histopathology, serology for
antibodies to infectious disease, and bacterial cultures.
Results: Severe bacteremia was identified as the main cause of death. Gastrointestinal (GI) damage
was observed in histopathology. The bacteremia was most likely caused by the translocation of
bacteria from the GI tract and immunosuppression caused by the myeloablative irradiation.
Variability in groups of animals affected was caused by increased levels of gamma and X-ray
radiation and the differing sensitivity of the two nearly genetically identical mouse strains used in
the studies.
Conclusion: Our retrospective analysis of thirty five murine BMTs performed in three different
laboratories, identified C57BL/6NCr (Ly5.1) as being more radiation sensitive than B6.Cg-Ptprca/
NCr (Ly5.2). This is the first report documenting a measurable difference in radiation sensitivity
and its effects between an inbred strain of mice and its congenic counterpart eventually succumbing
to sepsis after BMT.
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1. Introduction
Bone marrow transplantation (BMT) is a common ther-
apy for many neoplastic and non-neoplastic conditions
[1]. Current research is focused on the development of
more efficient transplant regimens and therapies [1].
Before receiving a donor bone marrow (BM) graft, BMT
patients undergo preparatory regimens (which often
include irradiation) to deplete the host BM. Complica-
tions of BMT include viral, bacterial or fungal infections
secondary to bone marrow ablation, and relapse of neo-
plastic disease [2,3]. Few human patients die directly from
the preparatory regimens (chemotherapy, radiation)
because of the availability of supportive care. However,
debilitated high risk transplant patients require careful
titration of the myeloablative therapy to prevent multior-
gan disease [4,5]. Some of these complications are related
to failure of engraftment. One of the most deleterious side
effects of allogeneic BMT (when donor and recipient are
genetically different) is graft-versus-host disease (GVHD)
[6]. Grafted donor cells recognize the host (recipient of
BMT) tissues as foreign leading to GVHD. Acute GVHD is
defined as a disease appearing within 100 days post-BMT
which targets the skin, liver, lung, thymus and secondary
lymphoid tissues [7].
The mouse is one of the most utilized animal models for
translational BMT studies. With the development of
inbred strains of mice, many discoveries in the field of
immunology, immunogenetics, and radiation oncology
have taken place [8]. Inbred strains of mice permit the
study of BMT in genetically identical and genetically vari-
able systems. Transplantation between animals within the
same strain allow for modeling of autotransplants or
transplants between genetically identical twins (syn-
geneic). Genetically different donor and recipient strains
allow modeling of transplantation between genetically
different individuals (allogeneic). The mice in this report
came from a number of BMT studies conducted by three
laboratories where they utilize inbred strains for both syn-
geneic and allogeneic BMTs. There are three groups of
BMT recipient per experiment: 1) syngeneic bone marrow
recipients (syngenic BMTs) in which all animals are
expected to survive. 2) allogeneic bone marrow recipients
(allogenic BMTs) in which animals are expected to even-
tually succumb to GVHD, and 3) experimental allogenic
transplant recipients (experimental transplants) which
receive allogeneic bone marrow with genetically induced
modifications or treatments thought to prevent or
decrease GVHD. Experimental animals are expected to
have improved survival compared to the allogeneic con-
trol groups.
In general, mice irradiated for BMT studies experience
lethargy and malaise of one week duration due to radia-
tion induced multisystem organ damage. Commonly, all
animals, whether syngeneic or allogeneic survive the post-
irradiation period. Syngeneic animals usually recover
within two weeks, while allogeneic groups experience a
biphasic illness. After the first week of irradiation sickness,
allogeneic recipients undergo a relatively short recovery
period prior to becoming sick for the second time due to
GVHD. Animals developing GVHD, die as early as 12–14
days post-BMT and as late as 30–40 days post-BMT
depending on the degree of genetic mismatch. Mice devel-
oping GVHD may exhibit diarrhea, skin lesions (ulcera-
tions) and overall lethargy and anorexia as a consequence
of the damage to the classical GVHD target organs (skin,
gastrointestinal tract, liver, thymus) [9] similar to man.
In our studies, we observed an unexpected increase in
mortality very early after transplantation. One of the most
striking findings was facial swelling in the affected ani-
mals. Premature deaths in experimental murine models of
BMT cause significant complications in interpretation of
the experimental results and delay it's translation to the
clinic. Furthermore, it greatly increases expense due to the
necessity of using large numbers of mice, as well as the
effort of the investigators. These economic factors, the
impact on experiment outcomes, and the humane consid-
erations all indicate the need to minimize premature
deaths and better understand the limitations of the ani-
mal models utilized for human research. In our studies
because of the difference in the non-GVHD related early
mouse deaths in both syngeneic and allogeneic BMTs, we
carefully evaluated the environmental, genetic, treatment,
and pathologic factors associated with early death in a
large group of BM transplanted mice.
2. Materials and methods
2.1 Mice
The strains of mice used as recipients in the discussed BMT
studies were; C57BL/6NCr referred to as Ly5.1 and B6.Cg-
Ptprca/NCr, commercially available as B6-LY5.2/Cr, and
referred throughout this manuscript as Ly5.2. The specific
background strain from which the Ly5.2 gene comes from
is unknown. There has been considerable confusion con-
cerning the correct nomenclature for alleles of the protein-
tyrosine phosphatase, receptor type c locus (Ptprc), for-
merly Ly5. Ly5.1 and Ly5.2 nomenclature is still com-
monly utilized in transplantation. The nomenclature used
in this manuscript is consistent with The Jackson Labora-
tory (Jax) mouse genome informatics and Charles River
Laboratories. Animals were housed in AAALAC accredited
specific pathogen free rodent facilities at the University of
Michigan in non-sterilized, ventilated racks and supplied
with commercial rodent food. Animals received tap water
from municipal sources until bone marrow transplanta-
tion at which time they received acidified water, pH of
2.9–3.1 for 21 days. All animals were negative for all path-
ogens included in the assessment profile (Charles River®)Journal of Translational Medicine 2008, 6:10 http://www.translational-medicine.com/content/6/1/10
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and tested at the vendor's facility prior to shipping. These
included: Ectromelia, Enzootic Diarrhea of Infant Mice,
Mouse Hepatitis Virus, Mouse Parvovirus, Minute Mouse
Virus, Reovirus-3, Sendai virus, Theiler's Murine Encepha-
lomyelitis Virus, Lymphocytic Choriomeningitis virus,
Adenovirus, Mycoplasma pulmonis, Polyoma virus, Pneu-
monia virus of mice, Cilia-associated Respiratory Bacillus.
Animals received from the National Cancer Institute
(NCI) were also negative for all bacterial, viral and proto-
zoal diseases mentioned above and documented in their
surveillance reports.
All procedures were approved by the University of Michi-
gan's Animal Care and Use Committee.
2.2 Irradiation and BMT
Prior to transplantation, all animals received a myeloabla-
tive radiation (from 800–1300 cGy) given in a single
dose, or split into two doses 3–4 hours apart as described
previously [10,11]. The laboratories used the gamma irra-
diator, Gammacell 40® (+/- 0.8 rad/min) MDS Nordion,
Inc. (Ontario, Canada) or an X-ray electrovoltage instru-
ment (Philips 250 kV orthovoltage unit, 4 rad/min). All
animals were placed in a Raddisk® (Braintree Scientific,
Braintree, MA) when irradiated in the Gammacell 40.
When exposed to X-rays animals were maintained in a
custom made ventilated Plexiglas restraining device. The
donor bone marrow recipients' immune system was
reconstituted intravenously via the tail vein with 5 × 106
bone marrow cells with or without isolated splenic T cells
(5 × 105 to 5 × 106 cells), total splenocytes or tumor cells
given on the same day of irradiation. BMTs were per-
formed in dedicated procedure rooms in the animal facil-
ities (under HEPA-filtered hoods) or the laboratories (in a
clean dedicated area for injection). The recipients were
placed in a tail vein injector (custom made) and a maxi-
mum of 250 µL of BM inoculum was delivered per ani-
mal. Transplanted animals were housed in separate rooms
from untreated mice.
2.3 Pathology
Severely ill animals that were identified 4–10 days post-
BMT in different experiments were humanely euthanized.
Organs (brain, thoracic and abdominal organs) were har-
vested and placed in 10% formalin for 24 hours and then
70% ethanol prior to slide preparation. The tissues were
cut at 5 µm in thickness and stained with H&E prior to
analysis.
2.4 Blood and tissue cultures
Animals were anesthetized and an intracardiac or orbital
terminal phlebotomy was performed. Blood and tissue
cultures of kidneys, liver, spleen, heart and lungs were
aseptically obtained and routinely processed.
2.5 In-house serology
177 naïve mice used as recipients were assessed in-house
(in addition to the health status reports from NCI and
Charles River Laboratories) for evidence of 13 viruses and
two bacteria using the Charles River Diagnostic Laborato-
ries Assessment Profile (Charles River®) ELISA as
described previously. Mice were from the same vendor
and were analyzed during the same time period when pre-
mature deaths were occurring. The 177 mice analyzed
(and chosen at random) belonged to the three investiga-
tors as they shared a common mouse arrival holding
room.
2.8 Retrospective study of common factors
We evaluated factors related to: laboratory personnel,
housing, BM inoculum differences, irradiation source
(gamma or X-ray), irradiation dose, time of year BMTs
were performed and housing location before and after
transplantation.
2.8 Statistical analysis
Satistical analysis was performed as described [12]. The
Wilcoxon rank test was used to analyze irradiation doses
and survival. p < 0.05 was considered statistically signifi-
cant. The Cohran-Mantel-Haenszel statistic for general
association was performed to compare season of year
(winter, spring, summer) and laboratory personel
(between three laboratories). p < 0.05 was considered sta-
tistical significant. Odds ratios with a 95% confidence
interval was performed when comparing radiation source
(X-ray or Gamma irradiator), animal holding rooms, or
inoculum differences. p < 0.05 considered statistically sig-
nificant.
3. Results
3.1 Physical exam of affected recipients and early deaths 
post-BMT
On physical exam affected mice were lethargic, had a
hunched posture and exhibited decreased mobility. The
most striking clinical sign was pronounced facial swelling
(Figure 1A). In some experiments as many as 100% of the
syngeneic controls died within a week (Table 1). When an
experiment was affected, 25–100% of the animals would
exhibit the specific clinical sign of facial swelling (Table
1).
3.2 Systemic bacterial infection identified in affected 
animals on gross and histopathology analysis
Necropsy was performed on animals that exhibited facial
swelling. Gross pathology revealed severe cervicothoracic
swelling (Figure 1B) restricted to the dermis and subcuta-
neous layers. The salivary glands and the submandibular
lymph nodes were often enlarged. Some cases exhibited
severe swelling of the tongue.Journal of Translational Medicine 2008, 6:10 http://www.translational-medicine.com/content/6/1/10
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Histopathology identified an acute, severe, locally exten-
sive, necrotizing cervical lymphadenitis and cellulitis with
many intralesional bacteria (Figure 1B,C,D). There was
also extensive necrosis in the liver (Figure 2B) and spleen.
Numerous organs including the heart and liver contained
abundant bacteria with no reaction (Figure 2A,B). Spleen,
lymph nodes (Figure 1B,C,D), blood, and bone marrow
(Figure 2C) were leukocyte deficient indicating a state of
immunosuppression. The villi of the small Intestine were
severely blunted and fused consistent with radiation
induced gastrointestinal damage (Figure 2D).
3.3 Commensal bacteria and their toxins identified in 
blood and tissues
In view of the above results, bacterial cultures were ana-
lyzed from twelve affected animals exhibiting the exact
same symptoms from different experiments. These cul-
tures revealed a mix of bacteria in both blood and tissues
including  Escherichia coli,  Pseudomonas spp.,  Enterococci
spp., Staphylococcus spp., and Streptococci spp.
3.4 In-house serological analysis of naive animals
We aimed to rule out the possibility that naïve mice
shipped from our vendors, and documented to be nega-
tive of all infectious diseases tested (described in materials
and methods) did not become positive after being housed
in our facilities. Therefore, 177 naïve animals (to be used
in future transplants and which were housed in a com-
mon room shared by the three investigators) were tested a
second time for the same pathogens utilizing the Charles
River Diagnostic Laboratories Assessment Profile,
(Charles River®) (refer to materials and methods). All ani-
mals were negative for all pathogens tested.
Gross examination showed marked facial and submandibular swelling (A) Figure 1
Gross examination showed marked facial and submandibular swelling (A). Histopathology of cervical (B) and mesenteric (C, D) 
lymph nodes showing acute, severe, necrotizing lymphdenitis and cellulitis with intralesional bacteria at 4× (B), 10× (C) and 20× 
(D) magnification. Acute severe necrosis (C) of mesenteric lymph node.
B
C D
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3.5 Multi-factorial analysis of BM transplanted animals
We retrospectively evaluated environmental, experimen-
tal and animal factors associated with the study including:
strain of mouse, housing location, experimental equip-
ment, the degree of irradiation, type of irradiation
(gamma or X-ray), time a year (winter, spring, summer),
laboratory (comparing BMTs from the three laboratories),
treatment (splenocytes or tumor cells). Factors that were
not common among the three laboratories involved were
cell preparations, procedure rooms, housing location of
transplanted animals, cell culture media, and surgical
instruments. The most important factor identified in the
early deaths was the dose of radiation and the genetic
background of the recipient mice. Affected mice were
identified to be among the C57BL/6NCr (Ly5.1) group
while B6.Cg-Ptrpca/NCr (Ly5.2) congenics were mini-
mally or not affected (Table 2). Statistically significant dif-
ferences in survival were found using a Wilcoxon rank test
between Ly5.1 and Ly5.2 animals that received irradiation
(Figure 3A,B). Increased mortality (p < 0.001) was
observed in the Ly5.1 mice that received ≥ 1100 cGy (Fig-
ure 3A). The strain of the donor mice, the inclusion of T
cells or splenocytes in the inoculum, and genetic compat-
ibility of the donor and recipient did not affect morbidity
and mortality. Radiation at, or under 1000 cGy in B6
Ly5.1 recipients had a significant (p < 0.001) improve-
ment in survival (Figure 3A and Table 3). When compar-
ing variables for survival with more than two levels
(laboratory and season), the test for general association
for the different laboratories had a p = 0.165 and seasonal
influence had a p = 0.116. Odds ratios between differ-
ences by animal room post BMT had p value for the chi-
square statistic of 0.10. Odds ratios for being more
affected with X-ray compared to gamma radiation had a p
= 0.35. Odds ratio for groups that did not receive neither
splenocytes nor tumor cells p = 0.62. We considered sta-
tistically significance if p < 0.05.
4. Discussion
In our studies we document the clear differences in mor-
tality between C57BL/6NCr (Ly5.1) and B6.Cg-Ptrpca/
NCr (Ly5.2)C57BL/6Cr mice in BMT studies that utilized
irradiation as the main immunosuppressive regimen for
translational transplant studies. When syngenic animals
(positive controls), which would otherwise survive,
started dying, this made the transplants uninterpretable.
The death of immunocompromised mice such as SCIDs
and Nude (nu/nu) mice are common when exposed to
bacterial, viral, parasitic or protozoal pathogens similar to
immunocompromised individuals [13-17]. However fol-
lowing BMT, despite transient immunosuppression,
immunocompetent transplanted animals usually survive
for greater than seven days after the immunoablative treat-
ment [10,18-23]. If there is lack of engraftment the ani-
mals will eventually succumb to infection secondary to
BM aplasia [24,25] and anemia or thrombocytopenia.
Premature death may occur if the BM inoculum is not suc-
cessfully delivered, or the delivered cells are unable to
engraft and repopulate the hemolymphatic system of the
new host. In the cases reported here, all animals were
given a BMT dose and were expected to survive the initial
immunosuppressive period. Failure to deliver an appro-
priate dose of viable cells is unlikely because the intrave-
nous tail vein injections were given by experienced
Table 1: C57BL/6NCr are sensitive to irradiation doses >1000 cGy.
Inoculum type Recipients First day Symptoms 
observed post BMT
#affected % affected Treatment Rads (cGy) Irradiator
BM+ Tc B6 (Ly5.1) 6 2/4 50 1300 split Xray
BM + splenocytes B6 (Ly5.1) 7 2/4 50 1100 single Xray
BM + Tc B6 (Ly5.1) 9 2/4 50 1100 single Xray
BM+Tc B6 (Ly5.1) 7 1/3 33 EL-4 1100 single Xray
BM+Tc B6 (Ly5.1) 7 3/12 25 EL-4 1100 single Xray
BM+T c B6 (Ly5.1) 6 2/6 33 EL-4 1100 single Xray
BM+Tc B6 (Ly5.1) 6 8/8 100 EL-4 1100 single Xray
BM+Tc B6 (Ly5.1) 6 11/20 55 1100 single gamma
BM+Tc B6 (Ly5.1) 6 2/4 50 1100 single gamma
BM+Tc B6 (Ly5.1) 6 4/5 80 1100 split gamma
BM+Tc B6 (Ly5.1) 5 4/6 66 1300 split gamma
BM+Tc B6 (Ly5.1) 5 9/11 81 MBL-2 1300 split gamma
BM+DC B6 (Ly5.1) 4 5/5 100 DC 1100 single X-ray
BM+Tc B6 (Ly5.1) 5 5/5 100 1100 single gamma
BM+Tc B6 (Ly5.1) 5 3/9 33 1000 single gamma
C57BL/6NCr underwent BMT and exhibited unexpected deaths. Animals were reconstituted with bone marrow (BM) and T-cells (Tc), or bulk 
splenocytes (splenocytes) or dendritic cells (DC). Symptoms started as early as day +4 post-transplantation. Some animals received MBL-2 or EL-
4 leukemia cells. Ionizing radiation was given in a single or fractionated (split) dose or administered with an X-ray diffraction instrument. Split 
regimens were delivered in two equal amounts separated at least 3 hours apart.Journal of Translational Medicine 2008, 6:10 http://www.translational-medicine.com/content/6/1/10
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individuals and the Ly5.2 mice that were not affected were
given the same dose, by the same route, and by the same
personnel as those mice that died prematurely.
Animals might die early if aged, debilitated or if burdened
by a subclinical infection that was not identified prior to
myeloablation. This effect has also been observed in the
clinic with elder or very critical patients [4]. In our studies,
the mice undergoing transplantation were 3–8 months
Histopathology of the heart (A), liver (B), bone marrow (C), and small intestine (D) Figure 2
Histopathology of the heart (A), liver (B), bone marrow (C), and small intestine (D). Acute, severe bacterial myocarditis with 
intralesional bacteria (A) 10×. Acute hepatic necrosis (arrow) (B) 20×. Leukocyte deficient bone marrow (C) 10×. Blunted villi 
(arrow) in small intestine (D) 10×.
A B 
C D 
Table 2: Improved survival of B6.Cg-Ptprca/NCr mice to radiation doses of 1000 and 1100 cGy.
Inoculum type Recip Symptoms #affected % affected Rads (cGy) Irradiator
BM B6 (Ly5.2) None 0/10 0 1000 (single) X-ray
BM B6 (Ly5.2) None 0/10 0 1000 (single) X-ray
BM B6 (Ly5.2) None 0/10 0 1000 (single) X-ray
BM+Tc B6 (Ly5.2) None 0/5 0 1100 (single) gamma
BM+Tc B6 (Ly5.2) none 0/9 0 1100 (single) gamma
BM+Tc B6 (Ly5.2) None 0/27 0 1100 (split) gamma
BM +Tc B6 (Ly5.2) None 0/30 0 1100 (split) gamma
BM+Tc B6 (Ly5.2) None 0/25 0 1100 (split) gamma
BM+ Tc B6 (Ly5.2) Yes 7/24 29% 1100 single gamma
B6.Cg-Ptprca/NCr (B6LY5.2/Cr), referred as Ly5.2 congenics, receiving similar radiation doses as shown in Table 1. Recipients were reconstituted 
in these experiments with either bone marrow (BM) alone or BM and T-cells (Tc).Journal of Translational Medicine 2008, 6:10 http://www.translational-medicine.com/content/6/1/10
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old and healthy (based on NCI's health reports). As previ-
ously mentioned, mice that receive myeloablative condi-
tioning prior to BMT survive the time period immediately
after the preparatory regimen (5–7 days post irradiation).
By day +14 post-BMT, there is immunological recovery
which is demonstrated by normal peripheral immune
reconstitution [26]. As is expected in in vivo studies, some
intra-animal variation may occur, however if a mortality
over 20% in the syngeneic controls is observed, one must
re-assess the experimental protocol. Mice receiving alloge-
neic BM, and T cells may die of severe GVHD after 2 weeks
post-transplantation. Depending on the T cell and BM
dose and the degree of mismatch, GVHD may develop
before 14 days post-BMT. However, 1) syngeneic controls
should survive and 2) facial swelling should not be
observed as it is not a feature of GVHD in mice.
The premature animal deaths in this study were independ-
ent of the transplant details (donor T cell source, person-
nel, housing, cell preparation, irradiation source, age and
sex of recipient or housing facilities). Some mouse viruses
have been documented to be immunosuppressive and
impede stem cell differentiation [27-32] possibly having
an influence in immune reconstitution and engraftment.
Serology of 177 naïve animals to be used at a later time as
either donor or recipients, were negative for all bacteria
and viruses including parvoviruses. The strain of the recip-
ient and the dose of irradiation were the two predominant
B6 (Ly5.1) mice are more sensitive to irradiation than B6-Ly5.2 Figure 3
B6 (Ly5.1) mice are more sensitive to irradiation than B6-Ly5.2. (A) Survival comparison in the Ly5.1 mice after dif-
ferent irradiation doses. Ly5.1 are susceptible to irradiation doses ≥ 1100 cGy. All animals received a BMT the same day of 
irradiation (B). Survival comparison between congenic B6-Ly5.2 mice and Ly5.1 mice post irradiation doses of 1100 cGy, 1000 
cGy or less. Ly5.2 mice are more radioresistant than Ly5.1 mice at TBI doses of 1100 cGy. *p < 0.001, **p = 0.068.Journal of Translational Medicine 2008, 6:10 http://www.translational-medicine.com/content/6/1/10
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factors influencing facial swelling and mortality in these
BMT models (Figure 3A,B).
We identified E. coli, Pseudomonas spp., Enterococcus and
Streptococci spp in the blood and tissues. These pathogens
have commonly been reported to affect immunocompro-
mised animals [33]. In order to prevent infections in BMT
mice some groups recommend treating the animals with
antibiotics in the water in order to minimize bacterial
contamination post irradiation. In our institution we uti-
lize acidified (hyper-chlorinated) water with a pH = 2.9–
3.0 [19,20] and have rarely experienced problems in mice
in these study protocols.
Based on previous studies [22,23], gut damage in animals
that are SPF (not germ free), have some degree of translo-
cation of bacterial toxins (e.g. LPS) and possibly bacteria
post-irradiation, which in turn causes a severe inflamma-
tory response and severe hypotension. This is known to be
mediated by TNFα and IL-1 inflammatory mediators [9].
However, and as previously mentioned, during uncompli-
cated bone marrow transplants, syngeneic animals
recover successfully after this period. Based on the blood
and tissue cultures and histopathology, we clearly docu-
ment that the affected mice were severely septic. Even
though death from sepsis may be expected in severely
immunocompromised mice if challenged with a patho-
gen, early death from sepsis on transplanted animals,
though possible, it is not common. In our studies, the sys-
temic peri-BMT preparatory regimen caused a degree of
damage where even syngeneic recipients were unable to
successfully recover from the early post-transplant period.
As documented, their deaths were likely caused by the
translocation of gastrointestinal bacteria and their toxins
into the circulation, and subsequently into other organ
systems. Such effects continue to be an important co-mor-
bidity factor in human BMTs [1].
Facial swelling has been documented in immunodeffi-
cient SCID mice after severe infections in their oropharyn-
geal regions [17,33]. Therefore, the swelling in our
animals can, in part, be explained by the autoinoculation
of bacteria during their vulnerable immunocompromised
period as described in SCID mice.
In our studies the dose of radiation was one major factor
in causing the premature deaths. It has been documented
that splitting a single radiation dose into two equal half
doses causes less GI damage [34]. Based on our retrospec-
tive study, we observed that only the animals that died at
the early time points post-BMT (4–8 days) and exhibited
facial swelling, were the mice that received the highest
radiation doses performed in the laboratories (1100–
1300 cGy). High radiation doses such as 1000 cGy have
been documented to be relatively toxic when given to
larger species such as dogs and man [35,36]. However,
many strains and stocks of mice have historically been
more resistant to irradiation (e.g. C3H strains) [37] while
others are significantly more sensitive (e.g. BALB/c) [38]
once again emphasizing the importance of genetics not
only in BMT match/mismatches, but in the susceptibility
to the preparatory regimens. These factors are also likely
to impact human BMT outcomes.
In our retrospective analysis we have been able to identify
that most of the animals affected have been C57BL/6NCr
(Ly5.1) (Table 1 and Figure 3). B6.Cg-Ptrpca/NCr (Ly5.2)
syngeneic recipients receiving 1000–1100 cGy irradiation
doses were less affected (Table 2 and Figure 3) by irradia-
tion and the differences were statistically significant (p <
0.001). This suggests that B6-Ly5.2 congenic mice are
therefore more resistant to irradiation. One group of B6-
Ly5.2 mice in Table 2 exhibited a 29% mortality. It is pos-
sible that 1100 cGy given in a single dose may be the radi-
ation limit that Ly5.2 mice can withstand in our hands.
We must mention that certain variability is always
observed when performing in vivo experiments (even in
Table 3: C57BL/6NCr survival at doses under 1000 cGy.
Inoculum type Recipients Symptoms #affected % affected Rads (cGy) Irradiator
BM+Tc B6 (Ly5.1) None 0/5 0 1000 single gamma
BM+Tc B6 (Ly5.1) None 0/5 0 800 split X-ray
BM+Tc B6 (Ly5.1) None 0/5 0 800 split gamma
BM+ Tc B6 (Ly5.1) None 0/5 0 900 single gamma
BM+ Tc B6 (Ly5.1) None 0/6 0 900 single gamma
BM+ Tc B6 (Ly5.1) None 0/5 0 900 single gamma
BM+ Tc B6 (Ly5.1) None 0/3 0 900 single gamma
BM+ Tc B6 (Ly5.1) None 0/6 0 1000 single gamma
BM+ Tc B6 (Ly5.1) None 0/6 0 900 single gamma
BM+ Tc B6 (Ly5.1) None 0/3 0 1000 single gamma
BM+ Tc B6 (Ly5.1) None 0/5 0 1000 single gamma
C57BL/6NCr that received ≤ 1000 cGy survived the bone marrow transplant.Journal of Translational Medicine 2008, 6:10 http://www.translational-medicine.com/content/6/1/10
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age matched and using inbred strains) and there can be
unknown factors which may impact (hopefully to a lesser
degree) the experimental outcomes. It is possible in the
case of Ly5.2 animals mentioned above that human error
calculating the irradiation dose may have influenced the
outcome of this experiment, especially if we assumed that
we are at the cusp of the maximal radiation dose tolerated
by Ly5.2 mice. It has been our experience that Ly5.2 ani-
mals that received 1300 cGy as a single dose had a 90%
mortality. In any case, and based on the number of ani-
mals included in this study, we show that Ly5.2 mice are
more resistant to radiation and that no mortalities are
observed when either splitting the 1100 radiation dose or
decreasing the overall amount of radiation. There are a
plethora of studies that have documented the link
between the susceptibility of ionizing radiation and the
genetic makeup [37-46] between different strains of mice
and also man. For example DNA-protein kinases (DNA-
Pks), which are important for DNA repair, were found to
be diminished in BALB/c and 129/SvJ compared to
C57BL/6 mice after being exposed to ionizing radiation
[47]. In our specific study, we document for the first time
a difference in sensitivity between two nearly genetically
identical strains commonly used in biomedical research.
Despite their nearly identical genetic makeup supported
by immunological tolerance by the absence of GVHD [48]
in allogeneic BMTs or rejection of skin grafts, there may
still remain enough genetic disparity between the two
strains to produce this observed difference in response to
radiation. The mechanism of this differential sensitivity is
unkown. It is possible that these two strains have differ-
ences in their DNA repair capabilities or radioprotective
processes. It has been shown that the release of toxic nitric
oxide radicals (NOr) can contribute to irradiation damage
and that low NOr release post-irradiation is radioprotec-
tive [49]. It is also possible that Ly5.2 recipients may have
decreased NOr release post irradiation compared to Ly5.1.
In conclusion, we have demonstrated for the first time a
measurable difference in radiation sensitivity and its
effects between two nearly genetically identical strains of
mice commonly used for translational studies where
C57BL/6NCr die of bacteremia more readily than B6.Cg-
Ptprca/NCr congenics at radiation doses over 1000 cGy.
Abbreviations
Graft-versus-host disease (GVHD), C57BL/6NCr (B6
Ly5.1 or Ly5.1), B6.Cg-Ptprca/NCr or B6-LY5.2/Cr
(Ly5.2), total body irradiation (TBI)
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